Search research articles
Contact Us
Filters
Showing results (61-70 of 254) with videos related to
Page
of 26
Sort By:
American Journal of Obstetrics and Gynecology
|
October 20, 2015
Triggers, bundles, protocols, and checklists--what every maternal care provider needs to know
Kavita Shah Arora, Larry E Shields, William A Grobman, et al.
Placenta
|
October 31, 2019
Granulocyte macrophage colony stimulating factor (GM-CSF), the critical intermediate of inflammation-induced fetal membrane weakening, primarily exerts its weakening effect on the choriodecidua rather than the amnion
Anudeepa Sharma, Deepak Kumar, Robert M Moore, et al.
American Journal of Obstetrics and Gynecology
|
June 11, 2017
A randomized open-label controlled trial of chlorhexidine-alcohol vs povidone-iodine for cesarean antisepsis: the CAPICA trial
Edward H Springel, Xiao-Yu Wang, Vanessa M Sarfoh, et al.
Seminars in Perinatology
|
August 2, 2003
What we have learned about the predictors of preterm birth
Robert L Goldenberg, Jay D Iams, Brian M Mercer, et al.
American Journal of Obstetrics and Gynecology
|
September 19, 2009
Latency and infectious complications after preterm premature rupture of membranes: impact of body mass index
Saju D Joy, Yuan Zhao, Brian M Mercer, et al.
American Journal of Perinatology
|
January 21, 2016
Waist-to-Hip Ratio versus Body Mass Index as Predictor of Obesity-Related Pregnancy Outcomes
Mollie McDonnold, Lisa M Mele, Leslie Myatt, et al.
American Journal of Obstetrics and Gynecology
|
January 4, 2006
Separation of amnion from choriodecidua is an integral event to the rupture of normal term fetal membranes and constitutes a significant component of the work required
Sunny Arikat, Ryan W Novince, Brian M Mercer, et al.
American Journal of Obstetrics and Gynecology
|
October 18, 2011
The antibiotic treatment of PPROM study: systemic maternal and fetal markers and perinatal outcomes
Brian M Mercer, Dennis T Crouse, Robert L Goldenberg, et al.
American Journal of Obstetrics and Gynecology
|
October 17, 2017
In an in-vitro model using human fetal membranes, 17-α hydroxyprogesterone caproate is not an optimal progestogen for inhibition of fetal membrane weakening
Deepak Kumar, Robert M Moore, Brian M Mercer, et al.
Seminars in Perinatology
|
August 2, 2003
What we have learned regarding antibiotic therapy for the reduction of infant morbidity after preterm premature rupture of the membranes
Brian M Mercer, Robert L Goldenberg, Anita F Das, et al.
Page
of 26
Search research articles
Search
Showing results (61-70 of 254) with videos related to
Sort By:
Page
of 26
American Journal of Obstetrics and Gynecology
|
October 20, 2015
Triggers, bundles, protocols, and checklists--what every maternal care provider needs to know
Kavita Shah Arora, Larry E Shields, William A Grobman, et al.
Placenta
|
October 31, 2019
Granulocyte macrophage colony stimulating factor (GM-CSF), the critical intermediate of inflammation-induced fetal membrane weakening, primarily exerts its weakening effect on the choriodecidua rather than the amnion
Anudeepa Sharma, Deepak Kumar, Robert M Moore, et al.
American Journal of Obstetrics and Gynecology
|
June 11, 2017
A randomized open-label controlled trial of chlorhexidine-alcohol vs povidone-iodine for cesarean antisepsis: the CAPICA trial
Edward H Springel, Xiao-Yu Wang, Vanessa M Sarfoh, et al.
Seminars in Perinatology
|
August 2, 2003
What we have learned about the predictors of preterm birth
Robert L Goldenberg, Jay D Iams, Brian M Mercer, et al.
American Journal of Obstetrics and Gynecology
|
September 19, 2009
Latency and infectious complications after preterm premature rupture of membranes: impact of body mass index
Saju D Joy, Yuan Zhao, Brian M Mercer, et al.
American Journal of Perinatology
|
January 21, 2016
Waist-to-Hip Ratio versus Body Mass Index as Predictor of Obesity-Related Pregnancy Outcomes
Mollie McDonnold, Lisa M Mele, Leslie Myatt, et al.
American Journal of Obstetrics and Gynecology
|
January 4, 2006
Separation of amnion from choriodecidua is an integral event to the rupture of normal term fetal membranes and constitutes a significant component of the work required
Sunny Arikat, Ryan W Novince, Brian M Mercer, et al.
American Journal of Obstetrics and Gynecology
|
October 18, 2011
The antibiotic treatment of PPROM study: systemic maternal and fetal markers and perinatal outcomes
Brian M Mercer, Dennis T Crouse, Robert L Goldenberg, et al.
American Journal of Obstetrics and Gynecology
|
October 17, 2017
In an in-vitro model using human fetal membranes, 17-α hydroxyprogesterone caproate is not an optimal progestogen for inhibition of fetal membrane weakening
Deepak Kumar, Robert M Moore, Brian M Mercer, et al.
Seminars in Perinatology
|
August 2, 2003
What we have learned regarding antibiotic therapy for the reduction of infant morbidity after preterm premature rupture of the membranes
Brian M Mercer, Robert L Goldenberg, Anita F Das, et al.
Page
of 26